Are these test results normal if you're on a GLP-1 like semaglutide or tirzepatide for people with insulin resistance?

What Blood Work Changes Are Expected on Tirzepatide or Semaglutide

When patients with insulin resistance begin our 30-Week Tirzepatide Reset protocol, their labs typically shift in predictable, positive ways. Fasting glucose often drops from the 110-140 mg/dL range into the 80-100 mg/dL zone within 4-6 weeks on low-dose tirzepatide cycling. A1C commonly falls 1.0-2.0 points in the first 10 weeks, which aligns with the metabolic healing we see when combining the medication with our lectin-free low-carb diet.

Liver enzymes like ALT and AST frequently normalize as visceral fat decreases and toxin burden is addressed with our Brown Detox Drops. Triglycerides can plummet 30-60% because tirzepatide improves insulin sensitivity, while HDL often rises 5-10 points. LDL particle size usually improves even if total LDL appears slightly elevated, a pattern we track closely using advanced lipid panels.

Red Flags vs Normal Variations in GLP-1 Users

Mild elevations in pancreatic enzymes (amylase, lipase) occur in about 15% of patients but rarely indicate pancreatitis when symptoms are absent. A modest rise in heart rate (5-8 bpm) is common and usually stabilizes. Thyroid panels may show temporary TSH suppression that normalizes with proper cycling; we never chase numbers in isolation.

Decreased appetite can lower protein intake, sometimes causing mild BUN elevation or reduced albumin. This is easily corrected by hitting our 1.2g per kg protein target from real foods in the 221 recipes from The 30-Week Tirzepatide Reset. Electrolyte shifts, especially lower magnesium or potassium, appear if patients skip our targeted mineral support during the first two 70-day cycles.

How Our Protocol Prevents Lab Abnormalities

The biggest mistake I see is relying on GLP-1 medications like semaglutide or tirzepatide without rebuilding metabolic health. Our approach cycles low doses strategically across three 70-day phases while layering Japanese-style walking, red light therapy, and chaotic intermittent fasting in maintenance. This prevents the rebound insulin resistance many experience when stopping cold turkey.

We monitor body composition with InBody scans rather than scale weight alone. Non-scale victories—better energy, reduced joint pain, improved blood pressure—matter more than any single lab value. Patients following the 69 Transformation Steps rarely see dangerous deviations because the protocol addresses root causes: lectin-driven inflammation, toxin overload, and broken hunger signals.

Real Patient Lab Transformations

Take John, a 58-year-old with insulin resistance and Type 2 diabetes. Baseline A1C was 7.8, fasting glucose 138, triglycerides 210. After 12 weeks on our protocol—low-dose tirzepatide, lectin-free meals, Detox Drops—his A1C fell to 6.1, glucose to 92, and triglycerides to 98. He maintained these gains 18 months later using the habits built during the 30 weeks. Results like these show why metabolic freedom, not medication dependency, is the true goal.